“I had the opportunity to build and co-led the Sensing and Actuation Pillar, a Front-End team at Ethicon tasked to create innovative solutions for smart laparoscopic sensing with Paulo. He demonstrated outstanding critical thinking, attentive listening and exceptional collaborating skills that we employed to establish our strategy and roadmap. He brought a deep breadth of expertise in optical sensing and data science that led to new concepts. Paulo has an exceptional ability to convey information to diverse audiences and was instrumental in discussions with upper management and stakeholders. He is also a dedicated mentor and I value the insights he regularly provided me with. His passion for growth, both personal and of others fostered an environment of learning and he was engaged in several upskilling initiatives, especially in the digital domain. I am confident that Paulo will continue to excel and to positively impact the organizations he will belong to.”
About
As a change agent, I use data, scientific insight and technology to lead product…
Activity
-
Excited about my first contribution to the core #Rstats codebase! 🚀 After almost 20 years of being an R user, it is great to finally give back -…
Excited about my first contribution to the core #Rstats codebase! 🚀 After almost 20 years of being an R user, it is great to finally give back -…
Liked by Paulo Bargo, PhD
-
Last call for speakers from Asia-Pacific for the #RinPharma APAC track! ⚠ You have 10 days for your submission, i.e. until 11 August 2024 ⌛ ➡…
Last call for speakers from Asia-Pacific for the #RinPharma APAC track! ⚠ You have 10 days for your submission, i.e. until 11 August 2024 ⌛ ➡…
Liked by Paulo Bargo, PhD
-
Meet Xiao-Yu Song a scientist and true innovator in eye health who leads our talented Global R&D team that creates cutting-edge products addressing…
Meet Xiao-Yu Song a scientist and true innovator in eye health who leads our talented Global R&D team that creates cutting-edge products addressing…
Liked by Paulo Bargo, PhD
Experience
Education
-
Oregon Health and Science University
PhD student in the department of Electrical Engineering. Worked in biomedical optics/biophotonics with cancer patients at St. Vincent Medical Center.
-
-
BS student in Electrical Engineering with focus in Telecommunications. Worked on optical fibers and general electronics.
Licenses & Certifications
Volunteer Experience
Publications
-
A RISK-BASED APPROACH FOR ASSESSING R PACKAGE ACCURACY WITHIN A VALIDATED INFRASTRUCTURE
This white paper addresses concerns raised by statisticians, statistical programmers, informatics teams, executive leadership, quality assurance teams and others within the pharmaceutical industry about the use of R and selected R packages as a primary tool for statistical analysis for regulatory submission work. When discussing validation of software systems two areas should be considered:
Infrastructure validation
Software validation
Infrastructure includes the server, OS…This white paper addresses concerns raised by statisticians, statistical programmers, informatics teams, executive leadership, quality assurance teams and others within the pharmaceutical industry about the use of R and selected R packages as a primary tool for statistical analysis for regulatory submission work. When discussing validation of software systems two areas should be considered:
Infrastructure validation
Software validation
Infrastructure includes the server, OS, necessary infrastructure software, etc… For example, a system may use a server running Redhat Enterprise Linux (RHEL) version 6 and several other infrastructure software pieces including proxy servers like Apache httpd. Documenting infrastructure (or the environment) is an essential part of the validation process and this validation could follow standard practices such as those proposed in GAMP5, particularly change control management. Discussions regarding infrastructure validation are not in scope of this paper.
The aim of this paper is to propose a possible risk-based approach for assessing R package accuracy within a validated infrastructure.
Many of the thoughts and ideas addressed in this paper are extracted, verbatim, from the R Validation Hub, a cross-industry initiative whose mission is to enable the use of R by the bio-pharmaceutical industry in a regulatory setting.
The paper reflects the current thinking of the R Validation Hub working group and may evolve over time. Additional detail will be provided via the website and future papers.Other authorsSee publication -
http://www.researchgate.net/profile/Paulo_Bargo2
List of publications
-
Skin Responses to Micro Scale Field Size of Solar-Simulated Radiation – Preliminary Evaluation by Reflectance Confocal Microscopy in vivo
Photochem Photobiol
Erythema and pigment responses of human skin following an acute exposure to ultraviolet radiation (UVR) are frequently used to determine the photosensitivity of the skin. In this study we investigated the responses of the skin to a micro-scale area of UVR exposure (MiR) and compared the responses to a macro-scale area of exposure (MaR). The fluence required to produce a minimally perceptible erythema (MED) using the MiR was found to be higher than that for the MaR. The erythema response…
Erythema and pigment responses of human skin following an acute exposure to ultraviolet radiation (UVR) are frequently used to determine the photosensitivity of the skin. In this study we investigated the responses of the skin to a micro-scale area of UVR exposure (MiR) and compared the responses to a macro-scale area of exposure (MaR). The fluence required to produce a minimally perceptible erythema (MED) using the MiR was found to be higher than that for the MaR. The erythema response extended beyond the exposed area and this became pronounced when the beam size was microscopic. Reflectance confocal microscopy in vivo revealed that MiR induced cellular alterations within a confined area of smaller dimensions than the area of exposure. Pigment responses were confined within the areas of cellular damage. The erythema expression of exposed skin recovered faster for the sites receiving MiR even when the applied fluence was higher than the MED for the MaR. Through the use of MiR we were able to visualize spatially dissimilar skin responses of erythema and pigmentation suggesting different cellular mechanisms.
Other authorsSee publication -
Non-invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL
Experimental Dermatology
The stratum corneum (SC) serves a primary function of skin barrier and understanding the kinetics of SC formation may provide great insight for skin diagnosis and evaluation of therapies. Besides trans-epidermal water loss (TEWL), few methods have been characterized to assess skin barrier non-invasively in vivo, particularly for dynamic measurements on the same specimen over time. The objective of this study was to characterize alternative non-invasive methods to evaluate the dynamic processes…
The stratum corneum (SC) serves a primary function of skin barrier and understanding the kinetics of SC formation may provide great insight for skin diagnosis and evaluation of therapies. Besides trans-epidermal water loss (TEWL), few methods have been characterized to assess skin barrier non-invasively in vivo, particularly for dynamic measurements on the same specimen over time. The objective of this study was to characterize alternative non-invasive methods to evaluate the dynamic processes involved in the recovery of normal human SC after total removal. TEWL, tryptophan fluorescence and reflectance confocal microscopy (RCM) were used to determine skin barrier function, cell turnover and epidermal morphology over a period of 10 days after total removal of the SC by tape stripping. The results show a biphasic recovery of TEWL over time, which contrasted with a linear increase of 2.3 μm/day in SC thickness. Tryptophan assessment of cell turnover also demonstrated a biphasic pattern attaining a maximum three to four times the levels of the control site 3 days after injury that slowly returned to baseline and displayed great correlation (R2 > 0.95) to viable epidermis thickness that also achieved a maximum about 3 days after injury with an approximate increase of 55%. When plotting the change of TEWL versus SC thickness, a single exponential function is observed [Δ-TEWL = 55 exp (−0.157×)] which contrasts with other proposed models. These methods were able to present rates for SC recovery processes beyond skin barrier (TEWL) that may provide new insights on kinetics of barrier formation for evaluation of skin conditions and treatments.
Other authorsSee publication
Patents
-
Micro-insult test and use therefor
Issued US US 20110092844
The present invention relates to a method for testing human skin and other biological tissues, and the use thereof for testing the effects of ingredients and compositions on such tissues in vivo
Other inventorsSee patent -
Device and method for demonstrating and quantifying skin texture
Filed US US 20060182323 A1
A device and a method for demonstrating skin texture are disclosed. The device includes a camera having a rotating linear analyzer and a polarized light source. The method includes taking a photograph of an individual using a device comprising a flash lamp having a rotating linear polarizer and a digital camera with a rotating linear analyzer, wherein the camera is positioned at 90 degrees from the flash lamp and the individual is placed such that the illumination angle to its surface normal is…
A device and a method for demonstrating skin texture are disclosed. The device includes a camera having a rotating linear analyzer and a polarized light source. The method includes taking a photograph of an individual using a device comprising a flash lamp having a rotating linear polarizer and a digital camera with a rotating linear analyzer, wherein the camera is positioned at 90 degrees from the flash lamp and the individual is placed such that the illumination angle to its surface normal is from about 45 degrees to about 135 degrees; exporting the photograph to a computer; and making a determination selected from the group consisting of the mean, the median, the intensity distribution and the autocorrelation on a region of interest of the image to demonstrate the texture of the skin
Other inventorsSee patent
Languages
-
Portuguese
Native or bilingual proficiency
-
Spanish
Native or bilingual proficiency
-
English
Native or bilingual proficiency
Organizations
-
SPIE
-
- Present
Recommendations received
6 people have recommended Paulo
Join now to viewMore activity by Paulo
-
Some exciting news! R/Pharma call-for-papers will remain open until July 31st. We will be running an APAC track this year. Call-for-papers for the…
Some exciting news! R/Pharma call-for-papers will remain open until July 31st. We will be running an APAC track this year. Call-for-papers for the…
Liked by Paulo Bargo, PhD
-
This August, the R/Pharma in-person summit is happening in Seattle! 🤔 What’s R/Pharma? The R/Pharma Summit is an in-person event on August 11th…
This August, the R/Pharma in-person summit is happening in Seattle! 🤔 What’s R/Pharma? The R/Pharma Summit is an in-person event on August 11th…
Liked by Paulo Bargo, PhD
-
Tenure Track Faculty Openings - Department of Medical Physics - University of Wisconsin Madison #AAPM #BME https://lnkd.in/gMG3vhtq
Tenure Track Faculty Openings - Department of Medical Physics - University of Wisconsin Madison #AAPM #BME https://lnkd.in/gMG3vhtq
Liked by Paulo Bargo, PhD
-
We are still accepting papers for this conference, we hope to see you there.
We are still accepting papers for this conference, we hope to see you there.
Liked by Paulo Bargo, PhD
-
Every top pharmaceutical company uses Posit for drug discovery and development. Why is that? It's simple. 1. Open source is fundamentally…
Every top pharmaceutical company uses Posit for drug discovery and development. Why is that? It's simple. 1. Open source is fundamentally…
Liked by Paulo Bargo, PhD
-
There will be dozen’s of speakers from Posit at posit::conf this year, below is an overview of what to look forward to: ⬡ Keynote: Updates from…
There will be dozen’s of speakers from Posit at posit::conf this year, below is an overview of what to look forward to: ⬡ Keynote: Updates from…
Liked by Paulo Bargo, PhD
-
Very excited to discuss the future of open source clinical reporting at the R/Pharma Summit on Aug 11th! Last year, we asked attendees how to best…
Very excited to discuss the future of open source clinical reporting at the R/Pharma Summit on Aug 11th! Last year, we asked attendees how to best…
Liked by Paulo Bargo, PhD
-
Call for speakers open for the #RinPharma for Asia-Pacific (APAC) track! Submit a topic here: https://lnkd.in/gbhC-uS2
Call for speakers open for the #RinPharma for Asia-Pacific (APAC) track! Submit a topic here: https://lnkd.in/gbhC-uS2
Liked by Paulo Bargo, PhD
-
We are hosting our first Monthly "R/Pharma Hangout" tomorrow, July 16th @ 12pm EST! You can add it to your calendar here: https://lnkd.in/gB7vjKdB…
We are hosting our first Monthly "R/Pharma Hangout" tomorrow, July 16th @ 12pm EST! You can add it to your calendar here: https://lnkd.in/gB7vjKdB…
Liked by Paulo Bargo, PhD
-
CALL FOR SPEAKERS R/Pharmahttps://lnkd.in/gWd8bgv2 #R #Rinpharma #pharma #callforspeakers
CALL FOR SPEAKERS R/Pharmahttps://lnkd.in/gWd8bgv2 #R #Rinpharma #pharma #callforspeakers
Liked by Paulo Bargo, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More